Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Cash Flow for Dividends : ¥-878 Mil (TTM As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Cash Flow for Dividends?

Tianjin Pharmaceutical Da Ren Tang Group's cash flow for dividends for the three months ended in Mar. 2024 was ¥-2 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-878 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Tianjin Pharmaceutical Da Ren Tang Group's quarterly payment of dividends increased from Sep. 2023 (¥-5 Mil) to Dec. 2023 (¥-6 Mil) but then declined from Dec. 2023 (¥-6 Mil) to Mar. 2024 (¥-2 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual payment of dividends increased from Dec. 2021 (¥-232 Mil) to Dec. 2022 (¥-387 Mil) and increased from Dec. 2022 (¥-387 Mil) to Dec. 2023 (¥-877 Mil).

Tianjin Pharmaceutical Da Ren Tang Group Cash Flow for Dividends Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Cash Flow for Dividends Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Dividends

Get a 7-Day Free Trial

-173.35

-232.61

-232.06

-387.44

-877.33

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Dividends	Get a 7-Day Free Trial															-1.05	-865.17	-4.66	-6.45	-2.22

Tianjin Pharmaceutical Da Ren Tang Group Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-878 Mil.

Tianjin Pharmaceutical Da Ren Tang Group Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Tianjin Pharmaceutical Da Ren Tang Group's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Cash Flow for Dividends

Traded in Other Exchanges

T14:Singapore

Address

No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193

Website

http://www.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines